Search

everythinglearnresearchcommunity

for

Search:↓

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Treatments for urinary symptoms often cause ejaculatory problems.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Endometriosis causes abdominal-pelvic pain, and while surgery and treatments help, pain often persists.

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

Moxibustion may help improve ovarian function by changing androgen levels.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

The gymnast's wrist pain and delayed menstruation are linked to intense exercise, requiring reduced activity and monitoring.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

These ovarian conditions cause high testosterone levels.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Many different biological, psychological, and social factors can cause sexual dysfunction in American women.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.